Millet seed extract,
does it really help with Reduction in hair loss and hair growth?
research showsThe Priorin trial tested a millet-plus-L-cystine-plus-pantothenic-acid combination, while the MePL trial tested a proprietary complex in which millet-derived miliacin was encapsulated in wheat polar lipids. Possible coactivity from the polar lipids was not separated, and no RCT of a single millet seed extract for hair loss was identified. This is an indeterminate rating because attribution is impossible, not a finding of no effect.
ads claimProducts present “millet oil,” “miliacin,” “root nutrition,” “extension of the growth phase,” and “reduced shedding.” The study formulations were not generic millet powder but multi-ingredient combinations or proprietary polar-lipid-encapsulated ingredients and cannot be assumed equivalent.
Useful facts when choosing a product
- The 2000 study formulation combined millet seed extract with L-cystine and calcium pantothenate.
- The 2020 MePL study used miliacin, a millet-derived triterpenoid, encapsulated in polar lipids.
- The positive MePL result was reduced telogen hair density; anagen density was not significantly different from placebo.
- Long-term safety and product equivalence data for generic millet seed extract are limited.
What the research actually shows
The Priorin trial combined millet extract with L-cystine and pantothenic acid. The MePL trial tested millet-derived miliacin encapsulated in wheat polar lipids and did not separate possible polar-lipid coactivity. No hair-loss RCT of a single millet seed extract was identified.
Why this is classified as ?
Priorin is a multi-ingredient product and MePL is a proprietary miliacin-wheat-polar-lipid complex. Polar-lipid coactivity was not separated, and no RCT of a single millet seed extract for hair loss exists, so no score is assigned and the rating is indeterminate.
Counterpoint. Signals exist for the full formulations, but the single-ingredient contribution is unknown.
Rejudgment record. Reassessment (cross-check reflected) — Priorin combines millet, L-cystine, and pantothenic acid, while MePL is a proprietary miliacin-wheat-polar-lipid complex with unseparated possible coactivity; no single-ingredient millet seed extract hair-loss RCT permits attribution, so the rating is indeterminate
Cross-check — Codex and Claude
Evidence Table
| Study | Design | Sample | Funding | Endpoint | Result | Weight |
|---|---|---|---|---|---|---|
| Gehring W, Gloor M. 2000 | Six-month randomized, double-blind, placebo-controlled trial | 40 | Unknown; commercial combination product | Anagen hair proportion by phototrichogram | The millet extract, L-cystine, and calcium pantothenate combination group moved from an abnormal anagen proportion into the normal range. | Supportive |
| Keophiphath M et al. 2020 | Multicenter, randomized, double-blind, placebo-controlled trial | 12 | Included Robertet Group-affiliated authors; linked to a branded ingredient | Telogen and anagen density by phototrichogram, scalp dryness, and hair brightness | Telogen density decreased versus placebo, but anagen density increased in both groups without a between-group difference. | Key |
| Proksch E et al. 2026 | Multicenter open-label uncontrolled exploratory study | 12 | Study of a Bayer commercial combination product | Hair density, growth coefficient, and anagen/telogen proportions | Reported improvements from baseline, but without placebo, natural recovery and regression effects cannot be separated. | Ancillary |
Receipt — 3 References
All 3 cited sources were verified for existence at the original page (as of 2026-07-11).
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-07-11 · Corrections: none
Cite this verdict
[Chamgap] Millet seed extract (Panicum miliaceum) x reduction in hair loss and hair growth — Evidence Grade ?. 3 cited sources checked. Source: https://health-receipt.pages.dev/en/verdicts/skin-hair/millet-seed-extract-hair-loss-growth/ · CC BY 4.0CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.
What this document does and does not do
Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.